Immunic to Participate in Investor Conferences in November Immunic to Participate in Investor Conferences in NovemberPR NewswireNEW YORK, Nov. 2, 2026 NEW YORK, Nov. 2, 2026 /PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX),a late-stage biotechnology company pioneering the development of novel oral...